Skip to main content
ARS Home » Pacific West Area » Davis, California » Western Human Nutrition Research Center » Obesity and Metabolism Research » Research » Research Project #447209

Research Project: Utilizing Precision Approaches to Refine Dietary Guidance of Americans to Reduce Chronic Disease

Location: Obesity and Metabolism Research

2025 Annual Report


Objectives
The following research project addresses a key unmet need of the USDA Human Nutrition Program, namely to test the metabolic impact of the Dietary Guidelines for Americans (DGA) which has immediate nutrition policy implications. Furthermore, this project aims to identify dietary response phenotypes that may be used to improve dietary-based interventions intended to prevent liver fat accumulation and associated cardiometabolic diseases.To achieve these goals, project scientists have designed an interdisciplinary effort leveraging tools from analytical chemistry, biochemistry, clinical nutrition, endocrinology, exercise biology, genetics, molecular biology, physiology, and psychological/CNS-based assessments - applying cutting edge phenotyping tools alongside complementary basic research experiments. Objective 1 is: Determine if achieving and maintaining a healthy body weight is the key health promoting recommendation of the Dietary Guidelines for Americans (DGA). Sub-objective 1.A: Determine if achieving and maintaining a healthy body weight improves cardiometabolic risk in persons at-risk for metabolic disease. Objective 2 is: Determine if individuals segregated by liver fat levels differ in their responses to meals with different macronutrient composition. Sub-objective 2.A: Determine, using an acute challenge meal (CM) protocol in Mexican American men and women, the fasting and postprandial responses to a high-fat CM and a low-fat CM. Sub-objective 2B: Determine if perceived chronic stress and stress system responsiveness partly explain variability among individuals with differing liver fat levels and who differentially respond to meals with different macronutrient composition. Sub-objective 2C: Determine whether resveratrol-mediated protein kinase A (PKA) activation increases the ABHD5 availability pool in hepatocytes and determine the impact of high sucrose or high fat on the efficacy of resveratrol in preventing hepatocytes from fat accumulation. Sub-objective 2D: Examine physiological stress load and perceived chronic stress as possible barriers to healthy eating behavior and whether this stress-eating relationship correlates with elevated metabolic disease risk (e.g., higher liver fat). Objective 3 is: Determine the metabolomic signatures associated with liver fat levels and their interactions with diet. Sub-objective 3A: Determine if a Mediterranean style diet as described in the Dietary Guidelines for Americans improves Liver Fat, plasma Trimethylamine-N Oxide, and the plasma metabolomic profile in response to weight loss and liver fat reduction. Sub-objective 3B: Determine and test the compositional changes of the gut microbiome in response to Mediterranean diet as described in the Dietary Guidelines for Americans and if altering the microbiome improves Liver Fat and plasma Trimethylamine-N Oxide. Sub-objective 3C: Pilot digital tools to improve adherence to dietary guidance as assessed by the healthy eating index (HEI) score. Sub-objective 3D: Evaluate the robustness and reliability of urinary biomarkers of food intake and examine biomarker correspondence to dietary assessment instruments.


Approach
Objective 1 Hypotheses are: 1A1: Cardiometabolic improvements resulting from the Dietary Guidelines for Americans (DGA)-based diet will be greater in women who are overweight/obese when energy intake is restricted to result in weight loss; 1.A.2: Cardiometabolic benefits of energy restriction will be greater in women consuming a higher quality diet based on the DGA compared to a typical American diet. Objective 2 Hypotheses are: 2A: Individuals’ ability to metabolize consumed calories will be inversely related to liver fat levels, and the preferential metabolism of fat will be associated with higher levels of liver fat.; 2.B.1: Consumption of highly palatable foods from a voluntary snack food buffet will positively associate with higher liver fat, and those participants will also display higher subjective stress and stress-induced cortisol hypo-responsiveness; 2.B.2: Among participants with higher liver fat, participants having greater rates of postprandial carbohydrate-to-fat oxidation (utilization) will be more susceptible to eating highly palatable foods after an acute mental stress challenge.; 2.C.1: Resveratrol increases the availability of Abhydrolase Domain Containing 5 (ABHD5) for Adipose Triglyceride Lipase (ATGL) lipolytic activity, which negates the adverse effect of Patatin-like Phospholipase Domain-containing Protein 3 (PNPLA3) 148M variant on ATGL for triglyceride lipolysis during a high glucose or high fat challenge; 2.C.2: Resveratrol improves triglyceride hydrolysis in hepatocytes of mice overexpressing PNPLA3 148M during a high glucose or high fat diet challenge via increase in the ABHD5 availability pool in hepatocytes; 3.A: A Dietary Guidelines Diet will improve liver fat levels and reduce plasma Trimethylamine N-oxide (TMAO), and shift the plasma metabolome profile in a fashion consistent with greater metabolic health (e.g. reduce branched chain fatty acids). A Randomized Control Trial will be conducted to address hypotheses under Objectives 1 and 3. The study under Objectives 1 and 3 will be an intervention trial with women volunteers randomized to one of three diet groups in a parallel design: 1. participants will consume a DGA-based test diet and maintain energy balance; 2. participants will consume a DGA-based diet, restricted in calories in order to stimulate body weight loss; and 3. participants will consume a diet based on the typical American diet, restricted in calories in order to stimulate body weight loss. For sub-objectives 2A and 2B under Objective 2, an acute challenge meal (CM) protocol in Mexican American men and women with varying degrees of liver fat, will be used to determine fasting and postprandial metabolic responses to a high-fat CM and a low-fat CM. For sub-objective 2C, a series of animal and cellular experiments will be conducted to assess the impact and cellular mechanisms of a polyphenolic compound, resveratrol, on liver metabolism


Progress Report
This report documents FY 2025 progress for project 2032-10700-003-000D, “Utilizing Precision Approaches to Refine Dietary Guidance of Americans to Reduce Chronic Disease”, which began in March 2024. ARS Researchers in Davis, California, continued to make progress on the human nutrition intervention study under Objective 1. In support of this objective, 13 additional study participants successfully completed the intervention, with 11 completing both intervention and post-intervention phases of the clinical nutrition research study. This represents more than a doubling of last year’s completion rate. Continued advertising and recruitment efforts were made. Study staff distributed flyers and conducted in-person tabling, and newspaper ads, local coupon book ads, and additional types of advertising were also utilized to reach potential study participants in local and surrounding cities. Over the past year, ARS researchers in Davis, California, recruited 149 participants, with 34 qualifying for in-person screening. Currently, five qualified participants are scheduled to start the intervention in 2025. ARS researchers also completed implementation of a liquid chromatography tandem mass spectrometry technique for the quantification of greater than 550 lipid species from 35 classes of compounds. They have used these methods to generate data from archived plasma samples of age matched men and women to explore associations with classical cardiovascular disease risk markers. These results were reported both locally and at a national conference. These methods have been used to further refine lipoprotein particle collection and analysis protocols to ensure sufficient sensitivity for their proposed lipidomic/metabolomic interrogation. In a subordinate project (UC Davis Biomarkers of Food Intake Consortium) funded by the USDA, ARS researchers in Davis, California, in collaboration with researchers at the University of California, Davis, continued efforts to identify quantitative plasma and urine biomarkers of specific fruit and vegetable intake. Study phase 1 using acute feeding of mixed fruit and vegetable doses to identify biomarkers was completed and data analysis is underway. A literature review of over 200 papers identified greater than 1,000 unique compounds previously reported to appear in the blood and/or urine after eating certain foods. A group of 85 compounds have been selected, solutions prepared, and chromatography optimized to establish an initial quantitative profiling tool for biomarkers of food intake. In a subordinate project (2032-51530-025-35R) funded by the National Institutes of Health and the Bill & Melinda Gates Foundation, ARS researchers in Davis, California, in collaboration with researchers at the University of California, Davis, performed metabolomic analyses on archived plasma samples from the Lao Thiamine Study to investigate the metabolome wide impacts of thiamine deficiency in children. Strong effects were observed on greater than 350 unique metabolites, with any previously reported impacts of thiamine deficiency on metabolism confirmed. The relative power of different branches of metabolism as diagnostic markers were delineated for the first time. Novel combinations of biomarkers of thiamine insufficiency have been proposed. These findings were reported to an international meeting of B-vitamin experts by invitation. In another subordinate project (2032-51530-025-65R) funded by the National Institutes of Health characterizing the endogenous function of a recently de-orphaned gene associated with kidney steroid metabolism in humans, ARS researchers in Davis, California, in collaboration with the University of California, San Francisco, expanded the characterization of the human SLC22A24 and SLC22A11 protein’s ability to transport steroids and bile acids. Methods developed in the last project period for steroid glucuronides and sulfates, along with unconjugated bile acids, were expanded and used to analyze cell culture systems expressing these proteins along with plasma and tissues from SLC22A24-transgenic mice, and humans with SLC22A24 and SLC22A11 gene variants. The methods will enhance the data collection in the parent project and the knowledge will enhance ARS's ability to interpret postprandial changes in lipids and associated metabolism in the parent project dietary interventions under Sub-objective 1B of the previous project. In a subordinate project (2032-51530-025-076N) investigating metabolomic biomarkers of Alzheimer’s disease risk and progression, ARS researchers in Davis, California, continue to participate in data interpretation and analysis meetings with collaborators at Duke University, the University of California, Davis, and the Alzheimer’s Disease Metabolomics Consortium. A manuscript was submitted defining an important role for epoxy fatty acid metabolism in Alzheimer’s disease, supporting novel therapeutic. This is an expansion of parent project Sub-objective 1D of the previous project. In a subordinate project (Mode Code/Log: 2032-15-05/0069132) funded by the Foundation for the National Institutes of Health, ARS researchers in Davis, California, in collaboration with researchers at the University of California, Davis, are investigating the roles of the soluble epoxide hydrolase and high density lipoprotein-mediated lipid mediator transport in the central nervous system of persons at risk for Alzheimer’s disease. In the current project period, support was provided for oxylipin profiling of isolated very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) particles. Data analysis is ongoing. This project is an expansion of Sub-objective 1D of the previous project. Under a subordinate project (58-2032-3-023-N), ARS researchers in Davis, California, in collaboration with researchers at the University of California, Davis, provided stake holder research support efforts aligned with our mission. In one study ARS researchers collaborated with researchers at the University of California, San Francisco, and a consortium of university hospitals in the United States with National Institutes of Health funding to investigate the dietary impact on multiple sclerosis severity and relapse in children. Methods established to measure short chain fatty acids in plasma were used to demonstrate that elevated plasma propionate was associated with decreased multiple sclerosis activity. It was also shown that metabolites of the amino acid tryptophane produced by gut microbes, if low, could be elevated through supplementation and improve symptoms in rodent models of multiple sclerosis. In another study, in collaboration with researchers at the City of Hope Comprehensive Cancer Center in Duarte, California, and The Ohio State University, the impact of long chain omega-3 fatty acid supplementation on breast tissue levels of anti-inflammatory mediators and proliferative gene expression was investigated in women with hormone-receptor negative breast cancer survivors. The dose responsive nature and duration of beneficial effects were demonstrated. In a California Almond Commission funded project with researchers from the University of California, Merced, ARS researchers helped to demonstrate that almond snacks had beneficial impacts on glucose metabolism as compared to crackers. In collaboration with researchers at the University of California, Davis, the lipid and bioactive lipid profiles of walnut pellicle and processing floor waste were characterized and shown to be a viable source for the commercial isolation of these bioactive materials. In another collaboration with University of California researchers studying the impact of the anti-diabetic drug metformin on Wilson’s disease, a genetic disease effecting liver copper accumulation, levels of inflammatory lipid mediators and bile acids were measured in the plasma, liver, and mitochondria of experimental mice. In general, these studies are expansions of Sub-objectives 1A and 2C, providing ancillary support to the parent project through staff support, analytical tool enrichment, and expanded understandings of integrated metabolism and nutrient interactions under a variety of conditions.


Accomplishments
1. Better mental control over food intake translated to healthier eating patterns in men, but not women. Eating patterns are significantly influenced by a balance between intrinsic motivation for certain foods and executive ability of the brain (cognitive restraint) to control what and how much one eats. ARS researchers in Davis, California, studied a cross section of 329 men and women to determine sex-dependent relationships between these factors and food intake patterns. Results showed that, although women had higher overall cognitive restraint, only men showed a relationship between higher cognitive restraint and healthier eating patterns. Overall, these results support targeted sex-dependent strategies for counseling clients towards more healthful dietary patterns.

2. Eating almond snacks improves a healthy person’s response to eating sugar. Nut consumption has health benefits but why this is true is still being determined. In collaboration with University of California researchers in Merced, California, ARS researchers in Davis, California, studied young adults consuming 325 calories of almonds or graham cracker snacks for 8-weeks, followed by an oral glucose tolerance test and metabolomic analyses for 20. Overall, almond consumption for 8-weeks led to dynamic, differential shifts in response to an acute glucose challenge marked by alterations in mediators of metabolic and physiological pathways. These findings demonstrate that exchanging 2 oz of almonds for an equivalent carbohydrate energy source can have beneficial impacts on the metabolic response to glucose in healthy subjects, supporting their inclusion in a healthy diet. If similar effects are observed in individuals with poor glucose regulation, it warrants future study.

3. Fish oil supplements can reduce drivers of breast cancer growth. Eating long chain omega-3 fatty acids may be beneficial for estrogen receptor and progesterone receptor negative (EPR-) breast cancer, but the mechanisms are not fully understood. In collaboration with researchers at the City of Hope Cancer Center in Duarte, California, and The Ohio State University, ARS researchers in Davis, California, studied women within five years of completing standard therapy for EPR- breast cancer fed either 1g or 5g of fish oil per day for one year. A dose of 5 g/d reduced triglycerides, increased breast tissue levels of long chain omega-3 fatty acids and their anti-inflammatory metabolites, and produced protective changes in DNA methylation. Increasing fish oil intake to a sufficient dose may represent an eminently feasible and tolerable preventive treatment for this high-risk breast cancer subtype.

4. Modeling metabolic predictors of weight loss. In collaboration with researchers at the University of North Carolina, Chapel Hill, ARS researchers in Davis, California, used a genetically diverse mouse model to identify metabolic markers that predict resistance to calorie restriction (CR)-induced weight loss. After inducing obesity in 300 Diversity Outbred mice, animals were subjected to an 8-week CR regimen. Results showed significant variability in weight loss response, with lower leptin levels predicting resistance to CR across both sexes. Additionally, sex-specific predictors were identified: lower glucose in males, and lower insulin, resistin, Homeostatic Model Assessment for Insulin Resistance(HOMA-IR), and Plasminogen activator inhibitor-1 (PAI-1), along with higher ghrelin levels in females. These findings demonstrate that genetically heterogeneous mouse models can uncover systemic metabolic predictors of weight loss responsiveness, providing a proof-of-principle for developing personalized obesity treatment strategies.

5. Early life dietary exposures influence bodyweight and the gut microbiome. In collaboration with researchers at University of California, Davis, ARS researchers demonstrated using mouse models that maternal exposure to antibiotics, protein deficiency, or vitamin D deficiency from preconception through lactation causes persistent changes in offspring gut microbiome diversity, composition, and bodyweight at adulthood, with effects significantly influenced by the genetic background of the parents. Notably, protein deficiency and antibiotic exposure led to ~15% lower bodyweight at 8-weeks, whereas vitamin D deficiency altered microbiota without growth suppression. This work provides critical proof that early-life environmental exposure interacts with maternal genetics to shape long-term gut health and growth trajectories, underscoring the need to optimize maternal nutrition during pregnancy and lactation.


Review Publications
Abbattista, R., Feinberg, N.G., Snodgrass, I.F., Newman, J.W., Dandekar, A.M. 2024. Unveiling the "hidden quality" of the walnut pellicle: A precious source of bioactive lipids. Frontiers in Plant Science. 15. Article 1395543. https://doi.org/10.3389/fpls.2024.1395543.
Bhetraratana, M., Orozco, L.D., Bennett, B.J., Luna, K., Yang, X., Lusis, A.J., Araujo, J.A. 2024. Diesel exhaust particle extract elicits an oxPAPC-like transcriptomic profile in macrophages across multiple mouse strains. Environmental Pollution. 358. Article 124415. https://doi.org/10.1016/j.envpol.2024.124415.
Paules, E.M., VerHague, M., Lulla, A.A., Meyer, K., Coleman, M.F., Albright, J., Bennett, B.J., North, K.E., Howard, A., Gordon-Larsen, P., Trujillo-Gonzalez, I., French, J.E., Hursting, S.D. 2025. Sex-specific systemic metabolic predictors of resistance to calorie restriction-induced weight loss in obese Diversity Outbred mice. American Journal of Physiology - Regulatory Integrative and Comparative Physiology. https://doi.org/10.1152/ajpregu.00220.2024.
Wulfridge, P., Davidovich, A., Salvador, A.C., Manno, G., Tryggvadottir, R., Idrizi, A., Huda, N., Bennett, B.J., Adams, L., Hansen, K.D., Threadgill, D.W., Feinberg, A.P. 2023. Precision pharmacological reversal of strain-specific diet-induced metabolic syndrome in mice informed by epigenetic and transcriptional regulation. PLoS Genetics. 19(10). Article e1010997. https://doi.org/10.1371/journal.pgen.1010997.
Tacad, D., Borkowski, K., Keim, N.L. 2025. Differential associations of eating behavior traits, food preference, motivations of food choice on diet intake and diet quality in adult females and males from the USDA Nutritional Phenotyping Study. Appetite. 213. Article 108048. https://doi.org/10.1016/j.appet.2025.108048.
De Leon, A., Burnett, D., Rust, B., Lyly, M., Keim, N.L. 2024. Initial implicit association between whole grains and taste does not predict consumption of whole grains in low-whole grain consumers: A pilot randomized controlled trial. Frontiers in Nutrition. 11. Article 1408256. https://doi.org/10.3389/fnut.2024.1408256.
Huda, M.N., Kelly, E., Barron, K., Xue, J., Valdar, W., Tarantino, L.M., Schoenrock, S., Ideraabdullah, F.Y., Bennett, B.J. 2025. The impact of early-life exposures on growth and adult gut microbiome composition is dependent on genetic strain and parent- of- origin. Microbiome. 13. Article 143. https://doi.org/10.1186/s40168-025-02130-w.
Oliver, A.S., Alkan, Z., Stephensen, C.B., Newman, J.W., Kable, M.E., Lemay, D.G. 2024. Diet, microbiome, and inflammation predictors of fecal and plasma short-chain fatty acids in humans. Journal of Nutrition. 154(11):3298-3311. https://doi.org/10.1016/j.tjnut.2024.08.012.
Chakraborty, H., Sun, Q., Bhupathiraju, S.N., Schenk, J.M., Mishchuk, D.O., Bain, J.R., He, X., Sun, J., Harnly, J.M., Simmons, W., Raftery, D., Liming, L., Newman, J.W., Fiehn, O., Clish, C.B., Lampe, J., Bennett, B.J., Navarro, S.L., Wang, Y., Zheng, C., Mossavar-Rahmani, Y., McCullough, M.L., Huang, Y., Shojaie, A., Zhu, W., Djukovic, D., Sacks, F., Williams, J., Steinberg, F.M., Adams, S.H., Hu, F.B., Neuhouser, M.L., Slupsky, C., Maruvada, P. 2025. The Dietary Biomarkers Development Consortium: An initiative for discovery and validation of dietary biomarkers for precision nutrition. Current Developments in Nutrition. 9(5). Article 107435. https://doi.org/10.1016/j.cdnut.2025.107435.
Lebedev, M., Walsh, P., Newman, J.W., Mutua, V.N., McEligot, H.A., Carvallo Chaigneau, F.R., Gershwin, L.J. 2025. Immune mechanisms affected by cyclooxygenase inhibition combined with antiviral treatment in calves infected with bovine respiratory syncytial virus. PLOS ONE. 20(4). Article e0321642. https://doi.org/10.1371/journal.pone.0321642.
Mukherjee, A., Bezwada, D., Greco, F., Zandbergen, M., Shen, T., Chiang, C., Tasdemir, M., Fahrmann, J., Grapov, D., La Frano, M.R., Vu, H.S., Faubert, B., Newman, J.W., McDonnell, L.A., Nezi, L., Fiehn, O., DeBerardinis, R., Lengyel, E. 2023. Adipocytes reprogram cancer cell metabolism by diverting glucose towards glycerol-3-phosphate thereby promoting metastasis. Nature Metabolism. 5:1563-1577. https://doi.org/10.1038/s42255-023-00879-8.
Wen, A., Zhu, Y., Yee, S., Park, B., Giacomini, K.M., Greenberg, A.S., Newman, J.W. 2023. The impacts of Slc19a3 deletion and intestinal SLC19A3 insertion on thiamine distribution and brain metabolism in the mouse. Metabolites. 13(8). Article 885. https://doi.org/10.3390/metabo13080885.
Ahmadi, A., Begue, G., Valencia, A.P., Norman, J.E., Lidgard, B., Bennett, B.J., Van Doren, M.P., Marcinek, D.J., Fan, S., Prince, D.K., Gamboa, J., Himmelfarb, J., de Boer, I.H., Kestenbaum, B.R., Roshanravan, B. 2023. Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease. Journal of Clinical Investigation. 8(11). Article e167274. https://doi.org/10.1172/jci.insight.167274.
Frankhouser, D.E., DeWees, T., Snodgrass, I.F., Cole, R.M., Steck, S., Thomas, D., Kalu, C., Belury, M.A., Clinton, S.K., Newman, J.W., Yee, L.D. 2025. Randomized dose-response trial of n–3 fatty acids in hormone receptor negative breast cancer survivors — Impact on breast adipose oxylipin and DNA methylation patterns. The American Journal of Clinical Nutrition. 122(1):70-82. https://doi.org/10.1016/j.ajcnut.2025.04.021.